Dr. Jon Hanifin, MD

Dermatology Portland, OR Male
NPI: 1336157882
Total Payments
$66,868
2022 Payments
$3,635
Companies
11
Transactions
50
Medicare Patients
14
Medicare Billing
$372.57

Payment Breakdown by Category

Consulting$37,083 (55.5%)
Travel$19,497 (29.2%)
Other$5,670 (8.5%)
Research$3,635 (5.4%)
Food & Beverage$983.36 (1.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $37,083 7 55.5%
Travel and Lodging $19,497 17 29.2%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $5,670 3 8.5%
Unspecified $3,635 1 5.4%
Food and Beverage $983.36 22 1.5%

Payments by Type

General
$63,233
49 transactions
Research
$3,635
1 transactions

Top Paying Companies

Company Total Records Latest Year
Otsuka Pharmaceutical Development & Commercialization, Inc. $25,951 5 $0 (2021)
UCB SA $18,659 15 $0 (2019)
AbbVie, Inc. $5,962 10 $0 (2017)
PFIZER INC. $5,765 7 $0 (2018)
GlaxoSmithKline, LLC. $5,367 2 $0 (2017)
Regeneron Pharmaceuticals, Inc. $3,635 1 $0 (2022)
LEO Pharma AS $1,236 5 $0 (2018)
Celgene Corporation $102.13 1 $0 (2019)
Horizon Pharma plc $92.23 1 $0 (2018)
Regeneron Healthcare Solutions, Inc. $87.58 2 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2022 $3,635 1 Regeneron Pharmaceuticals, Inc. ($3,635)
2021 $2,940 2 Otsuka Pharmaceutical Development & Commercialization, Inc. ($2,940)
2020 $3,430 1 Otsuka Pharmaceutical Development & Commercialization, Inc. ($3,430)
2019 $18,761 16 UCB SA ($18,659)
2018 $25,752 12 Otsuka Pharmaceutical Development & Commercialization, Inc. ($19,581)
2017 $12,349 18 AbbVie, Inc. ($5,962)

All Payment Transactions

50 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
12/01/2022 Regeneron Pharmaceuticals, Inc. DUPIXENT (Biological) — In-kind items and services $3,635.06 Research
Study: DUPIXENT CLINICAL DEVELOPMENT PROGRAM • Category: INFLAMMATION AND IMMUNOLOGY
10/20/2021 Otsuka Pharmaceutical Development & Commercialization, Inc. — Consulting Fee Cash or cash equivalent $980.00 General
04/06/2021 Otsuka Pharmaceutical Development & Commercialization, Inc. — Consulting Fee Cash or cash equivalent $1,960.00 General
07/29/2020 Otsuka Pharmaceutical Development & Commercialization, Inc. — Consulting Fee Cash or cash equivalent $3,430.00 General
05/20/2019 UCB SA — Travel and Lodging Cash or cash equivalent $10,821.00 General
05/20/2019 UCB SA — Travel and Lodging Cash or cash equivalent $62.90 General
05/20/2019 UCB SA — Travel and Lodging Cash or cash equivalent $39.68 General
05/06/2019 Celgene Corporation Otezla (Drug) Food and Beverage In-kind items and services $102.13 General
Category: Dermatology
05/02/2019 UCB SA — Consulting Fee Cash or cash equivalent $7,000.00 General
04/05/2019 UCB SA — Travel and Lodging In-kind items and services $34.79 General
04/05/2019 UCB SA — Food and Beverage In-kind items and services $28.06 General
04/04/2019 UCB SA — Travel and Lodging In-kind items and services $194.81 General
04/04/2019 UCB SA — Food and Beverage In-kind items and services $67.47 General
04/04/2019 UCB SA — Food and Beverage In-kind items and services $37.11 General
04/04/2019 UCB SA — Food and Beverage In-kind items and services $13.49 General
04/04/2019 UCB SA — Travel and Lodging In-kind items and services $10.12 General
04/03/2019 UCB SA — Travel and Lodging In-kind items and services $194.09 General
04/03/2019 UCB SA — Travel and Lodging In-kind items and services $72.82 General
04/03/2019 UCB SA — Food and Beverage In-kind items and services $54.90 General
04/03/2019 UCB SA — Food and Beverage In-kind items and services $28.01 General
11/06/2018 LEO Pharma AS — Travel and Lodging Cash or cash equivalent $157.00 General
11/06/2018 LEO Pharma AS — Food and Beverage Cash or cash equivalent $52.67 General
10/05/2018 LEO Pharma AS — Food and Beverage In-kind items and services $115.00 General
10/04/2018 LEO Pharma AS — Travel and Lodging In-kind items and services $684.65 General
10/04/2018 LEO Pharma AS — Travel and Lodging In-kind items and services $226.86 General
12»

Research Studies & Clinical Trials

Study Name Company Amount Records
DUPIXENT CLINICAL DEVELOPMENT PROGRAM Regeneron Pharmaceuticals, Inc. $3,635 1

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2020 1 14 16 $2,064 $372.57
Total Patients
14
Total Services
16
Medicare Billing
$372.57
Procedure Codes
1

All Medicare Procedures & Services

1 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 14 16 $2,064 $372.57 18.1%

About Dr. Jon Hanifin, MD

Dr. Jon Hanifin, MD is a Dermatology healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336157882.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jon Hanifin, MD has received a total of $66,868 in payments from pharmaceutical and medical device companies, with $3,635 received in 2022. These payments were reported across 50 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($37,083).

As a Medicare-enrolled provider, Hanifin has provided services to 14 Medicare beneficiaries, totaling 16 services with total Medicare billing of $372.57. Data is available for 1 year (2020–2020), covering 1 distinct procedure/service records.

Practice Information

  • Specialty Dermatology
  • Location Portland, OR
  • Active Since 08/03/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 207N00000X
  • Entity Type Individual
  • NPI Number 1336157882

Products in Payments

  • EUCRISA (Drug) $5,675
  • DUPIXENT (Biological) $3,635
  • Otezla (Drug) $102.13
  • ACTIMMUNE (Drug) $92.23
  • DUPIXENT DUPILUMAB INJECTION (Biological) $87.58
  • STELARA (Biological) $10.66

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Dermatology Doctors in Portland

Andrew Blauvelt, Md, MD

Dermatology — Payments: $2.6M

Dermatology $2.6M

Eric Simpson, Md, MD

Dermatology — Payments: $2.2M

Dermatology $2.2M

Benjamin Ehst, M.d., Ph.d, M.D., PH.D

Dermatology — Payments: $1.5M

Dermatology $1.5M

Dr. Jason Hawkes, Md, Ms, MD, MS

Dermatology — Payments: $876,779

Dermatology $876,779

Dr. Omar Qutub, Md, MD

Dermatology — Payments: $73,858

Dermatology $73,858

Alex Ortega Loayza, Md, MD

Dermatology — Payments: $72,824

Dermatology $72,824